5th ICHNO Programme Book

Influence on toxicity mucositis depending on contouring the oral cavity: our experience J. Marin (Spain), M.A. Garcia, I. Prieto, A.M. Perez Can the mean dose delivered to the superficial parotid lobe predict xerostomia following RT in HNC? D. Nevens (Belgium), S. Nuyts An evaluation of IMPT versus rotational IMRT for nasopharyngeal carcinoma T. Williams (United Kingdom), P. Sanghera, A. Hartley, G. Heyes, A. Dumbill, A. Chalkley, Y. Roussakis, J. Cashmore Cetuximab(CET), 5-FU and cisplatin or carboplatin (CA) versus CET, paclitaxel and CA in metastatic head and neck cancer S. Friesland (Sweden), L. Specht, H. Haugen, K. Söderström Genome-scale methylation assessment did not identify prognostic biomarkers in oral tongue carcinomas A. Lim (Australia), N. Wong, R. Pidsley, E. Zontenko, J. Corry, A. Dobrovic, B. Solomon, D. Rischin, S. Clark A re-evaluation of late mucosal toxicity: evidence for a mixed consequential-late effect? A. Hartley, P. Sanghera, J. Glaholm, C. McConkey, C. Boon (United Kingdom), S. Meade Combination of mTOR targeting with cetuximab, and chemotherapy: a preclinical study on head and neck cancer A. Bozec (France), N. Ebran, A. Sudaka, M.C. Etinne-Grimaldi, F. Penaud-Llorca, G. Milano E6 viral protein ratio correlates with outcomes in human papillomavirus related oropharyngeal cancer A. Hong (Australia), X. Zhang, D. Jones, M. Zhang, C.S. Lee, J.G. Lyons, A.S. Veillard, B. Rose Poster BIOLOGY, HPV, IMMUNOLOGY ANDMOLECULAR TARGETING

PO-093

PO-094

PO-095

PO-096

PO-097

PO-098

PO-099

PO-100

POSTERS | PROGRAMME & EXHIBITION GUIDE

28